# Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection

> **NCT02656511** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 74 (estimated)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Dolutegravir
- **DRUG:** Emtricitabine/Tenofovir

## Key facts

- **NCT ID:** NCT02656511
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-12
- **Primary completion:** 2027-05
- **Final completion:** 2028-05
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2025-06-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02656511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02656511, "Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02656511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*